Hemosyl 250 Tablet

Etamsylate (Ethamsylate)
250mg
Lomus Pharmaceutical Pvt. Ltd.
Pack size 100's
Dispensing mode
Source
Agent
Retail Price 14.00 NPR

Available as:

Indications

Hemosyl 250 Tablet is used for: Menorrhagia, Control of haemorrhage after surgery

Adult Dose

Oral Menorrhagia Adult: 500 mg 4 times daily during menstruation. Control of haemorrhage after surgery Adult: 250-500 mg every 4-6 hr as needed. May also be given via IV/IM inj.

Child Dose

Parenteral Treatment and prophylaxis of periventricular haemorrhage in low birth-weight neonates Child: Low birth-weight neonate: 12.5 mg/kg IM/IV Inj every 4-6 hr.

Renal Dose

Administration

May be taken with or without food. May be taken w/ meals to minimise GI upset.

Contra Indications

Hypersensitivity. Porphyria. Pregnancy and lactation.

Precautions

Pregnancy & breastfeeding.

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Etamsylate (Ethamsylate) : Headache, skin rash, nausea. IV: Transient hypotension.

Mechanism of Action

Ethamsylate stops haemorrhage from small blood vessels by stabilising the capillary wall and correcting abnormal platelet adhesion.

Note

Hemosyl 250 250mg Tablet manufactured by Lomus Pharmaceutical Pvt. Ltd.. Its generic name is Etamsylate (Ethamsylate). Hemosyl 250 is availble in Nepal. Farmaco Nepal drug index information on Hemosyl 250 Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Etamsylate (Ethamsylate) :